The p85 Adapter Subunit
Class IA PI3Ks are tightly associated with a 85 kDa regulatory subunit called p85.[2] P85 contains a Src homology 3 (SH3) domain, a breakpoint-cluster region homology (BH) domain between two proline-rich regions, and two C-terminal SH2 domains separated by an inter-SH2 (iSH2) region, which tightly binds p85 to the catalytic subunit.[3] Since PI3K has multiple protein-interaction domains, p85 is able to interact with several signaling molecules simultaneously, allowing for significant fine tuning of PI3K activity. [2]
Src Homology 3 (SH3) Domain
has homologues found in many intracellular signaling proteins. [4] It mediates protein-protein interactions by binding to proline-rich motifs in target proteins forming multimeric signaling complexes. [5] Of note, the SH3 domain interacts with Src (Src homology 2/α-collagen-related), CDC42GAP (Cdc42 GTPase-activating protein) and the proto-oncogene product Cbl. SH3 binds to proline rich ligands via a network of hydrophobic and hydrogen bond interactions, (3i5r).[4]
Proline-Rich Regions
The proline rich regions which flank the BH domain are ideal ligands for various SH3 containing non-receptor protein tyrosine kinases like Src, Lyn & Fyn, often with the product of the proteo-oncogene product Cbl as a docking site. [6]
Src Homology 2 (SH2) Domains
, an N-terminal (nSH2) domain and a C-terminal (CSH2) domain. [1] Both domains recognize similar consensus phosphorylated tyrosine motifs with the pattern: pY-V-X-M in activated receptors and adaptor proteins like PDGF, erbB3, c-Kit and CSF-1 receptors. [7] It is upon the interaction of receptor and SH2 domain that the heterodimeric PI3K complex is activated. [8] The (2iui), all of which coordinate the phosphorylated tyrosoine phosphate group.[9] nSH2 was found to interact with the catalytic subunit directly, forming a broad-based scaffold for p110α and coordinates communication between the interacting domains. (Discussed Below). [10]
BH Domain
The BH domain specifically interacts with the Rho family proteins, Cdc42 and Rac1. Although no crystal structure of the BH domain has been solved to date, mutagenesis experiments have verified that the conserved residues Arg 151, Lys 187 and Pro 270 play important roles in the interaction with Rac1 and Cdc42. [2]
Inter-SH2 (iSH2) Region
The (2v1y), is flanked by the two . The primary purpose of the iSH2 is to (3hhm), effectively holding the PI3K heterodimer together. In fact, disruption of this interaction via antibodies prevents the formation of the PI3K heterodimer completely. [2] It is further believed that binding of phosphopetide by the SH2 domains causes conformational strains which is [2]
Regulation of Class IA PI3K via p85 Phosphorylation
All PI3K catalytic subunits possess intrinsic protein serine kinase activity. PI3K regulatory subunits can be phophorylated by the catalytic subunit (p110) at specific sites. For example, phophorylation of Ser 608, a residue located in an area of the iSH2 domain that is critical for PIP2 presentation to the catalytic subunit, results in a dramatic reduction in PI3K lipid kinase activity.[11] Additionally, tyrosines 580 and 607 can be phosphorylated upon stimulation with insulin and growth factor along with . [2] Phosphorylation of Tyr 688 in the CSH2 domain by Abl and Lck results in reduced affinity for phosphopeptides and subsequent activation of the catalytic domain. [12]